As IGF-I promotes insulin sensitivity [50], this increase in circulating IGF-I may compensate for the lack of IGFBP-1 and explain why IGFBP-1-KO do not display impaired glucose tolerance or insulin resistance in line with population data in the literature. The gene discussed is INS; the disease is Impaired glucose tolerance.